Mycobacterium Bovis (Bovine Tuberculosis) in Humans
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Faqs 1. What Is a 2-Step TB Skin Test (TST)? Tuberculin Skin Test (TST
FAQs 1. What is a 2-step TB skin test (TST)? Tuberculin Skin Test (TST) is a screening method developed to evaluate an individual’s status for active Tuberculosis (TB) or Latent TB infection. A 2-Step TST is recommended for initial skin testing of adults who will be periodically retested, such as healthcare workers. A 2 step is defined as two TST’s done within 1month of each other. 2. What is the procedure for 2-step TB skin test? Both step 1 and step 2 of the 2 step TB skin test must be completed within 28 days. See the description below. STEP 1 Visit 1, Day 1 Administer first TST following proper protocol A dose of PPD antigen is applied under the skin Visit 2, Day 3 (or 48-72 hours after placement of PPD) The TST test is read o Negative - a second TST is needed. Retest in 1 to 3 weeks after first TST result is read. o Positive - consider TB infected, no second TST needed; the following is needed: - A chest X-ray and medical evaluation by a physician is necessary. If the individual is asymptomatic and the chest X-ray indicates no active disease, the individual will be referred to the health department. STEP 2 Visit 3, Day 7-21 (TST may be repeated 7-21 days after first TB skin test is re ad) A second TST is performed: another dose of PPD antigen is applied under the skin Visit 4, 48-72 hours after the second TST placement The second test is read. -
Latent Tuberculosis Infection
© National HIV Curriculum PDF created September 27, 2021, 4:20 am Latent Tuberculosis Infection This is a PDF version of the following document: Module 4: Co-Occurring Conditions Lesson 1: Latent Tuberculosis Infection You can always find the most up to date version of this document at https://www.hiv.uw.edu/go/co-occurring-conditions/latent-tuberculosis/core-concept/all. Background Epidemiology of Tuberculosis in the United States Although the incidence of tuberculosis in the United States has substantially decreased since the early 1990s (Figure 1), tuberculosis continues to occur at a significant rate among certain populations, including persons from tuberculosis-endemic settings, individual in correctional facilities, persons experiencing homelessness, persons who use drugs, and individuals with HIV.[1,2] In recent years, the majority of tuberculosis cases in the United States were among the persons who were non-U.S.-born (71% in 2019), with an incidence rate approximately 16 times higher than among persons born in the United States (Figure 2).[2] Cases of tuberculosis in the United States have occurred at higher rates among persons who are Asian, Hispanic/Latino, or Black/African American (Figure 3).[1,2] In the general United States population, the prevalence of latent tuberculosis infection (LTBI) is estimated between 3.4 to 5.8%, based on the 2011 and 2012 National Health and Nutrition Examination Survey (NHANES).[3,4] Another study estimated LTBI prevalence within the United States at 3.1%, which corresponds to 8.9 million persons -
Quantiferon-TB Gold In-Tube Blood Test, Tuberculosis
OFFICE OF DISEASE PREVENTION AND EPIDEMIOLOGY QuantiFERON™-TB Gold In-Tube How do people catch tuberculosis? What is a Tuberculosis (TB) is spread through the air from one person to another. The TB germs go into the air QuantiFERON test? whenever someone with TB disease in their lungs QuantiFERON (also called QFT) coughs or sneezes. People nearby may breathe in is a blood test to detect infection these germs and become infected. with tuberculosis. For the test, a health care worker will take some blood (less than a teaspoon) from your vein. The blood is then sent to a lab for testing. How soon will I have my test result? The test result will be available in 5–7 days. What is the difference between latent How are the test TB infection and TB disease? results interpreted? If the test is positive, it is likely People with latent TB infection (also called LTBI) you were exposed to tuberculosis are infected with the TB germ, but they do not feel and that you have latent sick or have any symptoms. They cannot spread tuberculosis infection (LTBI). TB to others because the TB germ is sleeping and not active. The only sign of LTBI is a positive A chest X-ray should be done reaction to the TB skin test or a TB blood test, to make sure you do not have such as QuantiFERON. TB disease in your lungs. QuantiFERON, like the TB Without treatment, LTBI can sometimes become skin test, can sometimes give TB disease. This occurs when the “sleeping” germs false results. -
Mycobacteria of Veterinary Interest
Rev. salud pública. 12 sup (2): 67-70, 2010 Virulence and pathogenicity - Conferences 67 Poster Presentation Mycobacteria of veterinary interest Production and potency of PPDs Mycobacterium phlei and Mycobacterium fortuitum isolated soils from La Pampa-Argentina Amelia Bernardelli1, Bernardo Alonso2, Delia Oriani3 1 SENASA, Dirección de Laboratorio y Control Técnico(DILAB),Lab. de Referencia en Paratuberculosis y Tuberculosis Bovina de la OIE, Buenos Aires-Republica Argentina. 2 SENASA (DILAB). 3 Universidad Nacional de La Pampa, Facultad de Ciencias Veterinarias, Cátedra de Microbiología, Gral. Pico, La Pampa -Republica Argentina. The Non-Tuberculous Mycobacteria (NTM),whose habitat the environment has ac- quired importance in the last years because of the immunosupressed patients, in- fected HIV ,and also in develop countries that have managed to eradicated the bovine tuberculosis. Where it has been verified that certain NTM interfere in the diagnosis of tuberculosis when it is applied to the delayed hypersensitivity test with purified protein derivative (PPD) tuberculin from Mycobacterium bovis. In the works to field exists controversy about the relevance of these environmental mycobacteria when control and eradication of animal tuberculosis are applied.The production of PPDs from the isolated soils from the province of La Pampa and the verification of the possible crossed reaction with bovine tuberculin PPD, prescribed test for international trade. Two lots of PPDs corresponding of M. phlei and M. fortuitum were elaborated with a protein content of 1.5mg/mL both.Guinea pigs were sensitized with dead M. phlei, M. fortuitum and M. bovis.After 60 days the potency tests were made bioassay at the guinea pigs, using also like standard of reference bovine PPD,Lot.N°5 DILAB and employing a Latin square design. -
Quantiferon®-TB Gold
QuantiFERON®-TB Gold ERADICATING TUBERCULOSIS THROUGH PROPER DIAGNOSIS AND DISEASE PREVENTION TUBERCULOSIS Tuberculosis (TB) is caused by exposure to Mycobacterium tuberculosis (M. tuberculosis), which is spread through the air from one person to another. At least two billion people are thought to be infected with TB and it is one of the top 10 causes of death worldwide. To fight TB effectively and prevent future disease, accurate detection and treatment of Latent Tuberculosis Infection (LTBI) and Active TB disease are vital. TRANSMISSION M. tuberculosis is put into the air when an infected person coughs, speaks, sneezes, spits or sings. People within close proximity may inhale these bacteria and become infected. M. tuberculosis usually grows in the lungs, and can attack any part of the body, such as the brain, kidney and spine. SYMPTOMS People with LTBI have no symptoms. People with Other symptoms can include: TB disease show symptoms depending on the infected area of the body. TB disease in the lungs ■ Chills may cause symptoms such as: ■ Fatigue ■ Fever ■ A cough lasting 3 weeks or longer ■ Weight loss and/or loss of appetite ■ Coughing up blood or sputum ■ Night sweats ■ Chest pain SCREENING To reduce disparities related to TB, screening, prevention and control efforts should be targeted to the populations at greatest risk, including: ■ HEALTHCARE ■ INTERNATIONAL ■ PERSONS WORKERS TRAVELERS LIVING IN CORRECTIONAL ■ MILITARY ■ RESIDENTS OF FACILITIES PERSONNEL LONG-TERM CARE OR OTHER FACILITIES CONGREGATE ■ ELDERLY PEOPLE SETTINGS ■ PEOPLE WITH ■ ■ STUDENTS WEAKENED CLOSE CONTACTS IMMUNE SYSTEMS OF PERSONS KNOWN OR ■ IMMIGRANTS SUSPECTED TO HAVE ACTIVE TB BIOCHEMISTRY T-lymphocytes of individuals infected with M. -
Recovery of <I>Salmonella, Listeria Monocytogenes,</I> and <I>Mycobacterium Bovis</I> from Cheese Enteri
47 Journal of Food Protection, Vol. 70, No. 1, 2007, Pages 47–52 Copyright ᮊ, International Association for Food Protection Recovery of Salmonella, Listeria monocytogenes, and Mycobacterium bovis from Cheese Entering the United States through a Noncommercial Land Port of Entry HAILU KINDE,1* ANDREA MIKOLON,2 ALFONSO RODRIGUEZ-LAINZ,3 CATHY ADAMS,4 RICHARD L. WALKER,5 SHANNON CERNEK-HOSKINS,3 SCARLETT TREVISO,2 MICHELE GINSBERG,6 ROBERT RAST,7 BETH HARRIS,8 JANET B. PAYEUR,8 STEVE WATERMAN,9 AND ALEX ARDANS5 1California Animal Health and Food Safety Laboratory System (CAHFS), San Bernardino Branch, 105 West Central Avenue, San Bernardino, California 92408, and School of Veterinary Medicine, University of California, Davis, California 95616; 2Animal Health & Food Safety Services Downloaded from http://meridian.allenpress.com/jfp/article-pdf/70/1/47/1680020/0362-028x-70_1_47.pdf by guest on 28 September 2021 Division, California Department of Food and Agriculture, 1220 North Street, Sacramento, California 95814; 3California Office of Binational Border Health, California Department of Health Services, 3851 Rosecrans Street, San Diego, California 92138; 4San Diego County Public Health Laboratory, 3851 Rosecrans Street, San Diego, California 92110; 5CAHFS-Davis, Health Sciences Drive, School of Veterinary Medicine, University of California, Davis, California 95616; 6Community Epidemiology Division, County of San Diego Health and Human Services, 1700 Pacific Highway, San Diego, California 92186; 7U.S. Food and Drug Administration, 2320 Paseo De -
Chapter 2, Transmission and Pathogenesis of Tuberculosis (TB)
Chapter 2 Transmission and Pathogenesis of Tuberculosis Table of Contents Chapter Objectives . 19 Introduction . 21 Transmission of TB . 21 Pathogenesis of TB . 26 Drug-Resistant TB (MDR and XDR) . 35 TB Classification System . 39 Chapter Summary . 41 References . 43 Chapter Objectives After working through this chapter, you should be able to • Identify ways in which tuberculosis (TB) is spread; • Describe the pathogenesis of TB; • Identify conditions that increase the risk of TB infection progressing to TB disease; • Define drug resistance; and • Describe the TB classification system. Chapter 2: Transmission and Pathogenesis of Tuberculosis 19 Introduction TB is an airborne disease caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis) (Figure 2.1). M. tuberculosis and seven very closely related mycobacterial species (M. bovis, M. africanum, M. microti, M. caprae, M. pinnipedii, M. canetti and M. mungi) together comprise what is known as the M. tuberculosis complex. Most, but not all, of these species have been found to cause disease in humans. In the United States, the majority of TB cases are caused by M. tuberculosis. M. tuberculosis organisms are also called tubercle bacilli. Figure 2.1 Mycobacterium tuberculosis Transmission of TB M. tuberculosis is carried in airborne particles, called droplet nuclei, of 1– 5 microns in diameter. Infectious droplet nuclei are generated when persons who have pulmonary or laryngeal TB disease cough, sneeze, shout, or sing. Depending on the environment, these tiny particles can remain suspended in the air for several hours. M. tuberculosis is transmitted through the air, not by surface contact. Transmission occurs when a person inhales droplet nuclei containing M. -
Mycobacterium Tuberculosis: Assessing Your Laboratory
A more recent version of this document exists. View the 2019 Edition. Mycobacterium tuberculosis: Assessing Your Laboratory APHL Tool 2013 EDITION The following individuals contributed to the preparation of this edition of Mycobacterium tuberculosis: Assessing Your Laboratory Phyllis Della-Latta, PhD Columbia Presbyterian Medical Center Loretta Gjeltena, MA, MT(ASCP) National Laboratory Training Network Kenneth Jost, Jr. Texas Department of State Health Services Beverly Metchock, DrPH Centers for Disease Control and Prevention Glenn D. Roberts, PhD Mayo Clinic Max Salfinger, MD Florida Department of Health, Florida Bureau of Laboratories Dale Schwab, PhD, D(ABMM) Quest Diagnostics Julie Tans-Kersten Wisconsin State Laboratory of Hygiene Anthony Tran, MPH, MT(ASCP) Association of Public Health Laboratories David Warshauer, PhD, D(ABMM) Wisconsin State Laboratory of Hygiene Gail Woods, MD University of Texas Medical Branch Kelly Wroblewski, MPH, MT(ASCP) Association of Public Health Laboratories This publication was supported by Cooperative Agreement Number #1U60HM000803 between the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. © Copyright 2013, Association of Public Health Laboratories. All Rights Reserved. Table of Contents 1.0 Introduction ...................................................4 Background ...................................................4 Intended -
Mycobacterium Bovis, Summer Food Safety and Adolescent Immunizations
Mycobacterium Bovis, Summer Food Safety and Adolescent Immunizations Summer 2013 Mycobacterium Bovis In the United States, the majority of tuberculosis (TB) cases in people are caused by Mycobacterium tuberculosis (M. tuberculosis). Mycobacterium bovis (M. bovis) is another mycobacterium that can cause TB disease in people. M. bovis causes a relatively small proportion, less than 2%, of the total number of cases of TB disease in the United States. This accounts for less than 230 TB cases per year in the United States. M. bovis transmission from cattle to people was once common in the United States. This has been greatly reduced by decades of disease control in cattle and by routine pasteurization of cow’s milk. People are most commonly infected with M. bovis by eating or drinking contaminated, unpasteurized dairy products. The pasteurization process, which destroys disease-causing organisms in milk by rapidly heating and then cooling the milk, eliminates M. bovis from milk products. Infection can also occur from direct contact with a wound, such as what might occur during slaughter or hunting, or by inhaling the bacteria in air exhaled by animals infected with M. bovis. Direct transmission from animals to humans through the air is thought to be rare, but M. bovis can be spread directly from person to person when people with the disease in their lungs cough or sneeze. Not all M. bovis infections progress to TB disease, so there may be no symptoms at all. In people, symptoms of TB disease caused by M. bovis are similar to the symptoms of TB caused by M. -
Tuberculosis Caused by Mycobacterium Bovis Infection in A
Ikuta et al. BMC Veterinary Research (2018) 14:289 https://doi.org/10.1186/s12917-018-1618-6 CASEREPORT Open Access Tuberculosis caused by Mycobacterium bovis infection in a captive-bred American bullfrog (Lithobates catesbeiana) Cassia Yumi Ikuta2* , Laura Reisfeld1, Bruna Silvatti1, Fernanda Auciello Salvagni2, Catia Dejuste de Paula2, Allan Patrick Pessier3, José Luiz Catão-Dias2 and José Soares Ferreira Neto2 Abstract Background: Tuberculosis is widely known as a progressive disease that affects endothermic animals, leading to death and/or economical losses, while mycobacterial infections in amphibians are commonly due to nontuberculous mycobacteria. To the authors’ knowledge, this report describes the first case of bovine tuberculosis in a poikilothermic animal. Case presentation: An adult female captive American bullfrog (Lithobates catesbeianus Shaw, 1802) died in a Brazilian aquarium. Multiple granulomas with acid-fast bacilli were observed in several organs. Identification of Mycobacterium bovis was accomplished by culture and PCR methods. The other animals from the same enclosure were euthanized, but no evidence of mycobacterial infection was observed. Conclusions: The American bullfrog was introduced in several countries around the world as an alternative husbandry, and its production is purposed for zoological and aquarium collections, biomedical research, education, human consumption and pet market. The present report warns about an episode of bovine tuberculosis in an amphibian, therefore further studies are necessary to define this frog species’ role in the epidemiology of M. bovis. Keywords: Amphibian, Bovine tuberculosis, Bullfrog, Mycobacterium bovis Background most NTM infections in amphibians are thought to be The genus Mycobacterium comprises several species, opportunistic and acquired from environmental sources, such as members of the Mycobacterium tuberculosis such as soil, water and biofilms [5, 6]. -
Diagnosis of Tuberculosis in Adults and Children David M
Clinical Infectious Diseases IDSA GUIDELINE Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children David M. Lewinsohn,1,a Michael K. Leonard,2,a Philip A. LoBue,3,a David L. Cohn,4 Charles L. Daley,5 Ed Desmond,6 Joseph Keane,7 Deborah A. Lewinsohn,1 Ann M. Loeffler,8 Gerald H. Mazurek,3 Richard J. O’Brien,9 Madhukar Pai,10 Luca Richeldi,11 Max Salfinger,12 Thomas M. Shinnick,3 Timothy R. Sterling,13 David M. Warshauer,14 and Gail L. Woods15 1Oregon Health & Science University, Portland, Oregon, 2Emory University School of Medicine and 3Centers for Disease Control and Prevention, Atlanta, Georgia, 4Denver Public Health Department, Denver, Colorado, 5National Jewish Health and the University of Colorado Denver, and 6California Department of Public Health, Richmond; 7St James’s Hospital, Dublin, Ireland; 8Francis J. Curry International TB Center, San Francisco, California; 9Foundation for Innovative New Diagnostics, Geneva, Switzerland; 10McGill University and McGill International TB Centre, Montreal, Canada; 11University of Southampton, United Kingdom; 12National Jewish Health, Denver, Colorado, 13Vanderbilt University School of Medicine, Vanderbilt Institute for Global Health, Nashville, Tennessee, 14Wisconsin State Laboratory of Hygiene, Madison, and 15University of Arkansas for Medical Sciences, Little Rock Downloaded from Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuber- culosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. -
Biosynthesis of Isonitrile Lipopeptides by Conserved Nonribosomal Peptide Synthetase Gene Clusters in Actinobacteria
Biosynthesis of isonitrile lipopeptides by conserved nonribosomal peptide synthetase gene clusters in Actinobacteria Nicholas C. Harrisa, Michio Satob, Nicolaus A. Hermanc, Frederick Twiggc, Wenlong Caic, Joyce Liud, Xuejun Zhuc, Jordan Downeyc, Ryan Khalafe, Joelle Martine, Hiroyuki Koshinof, and Wenjun Zhangc,g,1 aDepartment of Plant and Microbial Biology, University of California, Berkeley, CA 94720; bDepartment of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan; cDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, CA 94720; dDepartment of Bioengineering, University of California, Berkeley, CA 94720; eDepartment of Chemistry, University of California, Berkeley, CA 94720; fRIKEN Physical Center for Sustainable Resource Science, Wako, Saitama 3510198, Japan; and gChan Zuckerberg Biohub, San Francisco, CA 94158 Edited by Jerrold Meinwald, Cornell University, Ithaca, NY, and approved May 26, 2017 (received for review March 27, 2017) A putative lipopeptide biosynthetic gene cluster is conserved in many dependent oxidase, a fatty acyl-CoA thioesterase, an acyl-acyl species of Actinobacteria, including Mycobacterium tuberculosis and carrier protein ligase (AAL), an acyl carrier protein (ACP), and M. marinum, but the specific function of the encoding proteins has a single- or dimodule NRPS, respectively (Fig. 1 and SI Appendix, been elusive. Using both in vivo heterologous reconstitution and Fig. S1). Although all of these five proteins are typically involved in in vitro biochemical analyses, we have revealed that the five encod- secondary metabolite biosynthesis, the identity of the correspond- ing biosynthetic enzymes are capable of synthesizing a family of ing metabolite and the specific function of these proteins have not isonitrile lipopeptides (INLPs) through a thio-template mechanism.